These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34878295)

  • 21. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
    Khatua B; Roy S; Mandal C
    Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separate pathways for O acetylation of polymeric and monomeric sialic acids and identification of sialyl O-acetyl esterase in Escherichia coli K1.
    Steenbergen SM; Lee YC; Vann WF; Vionnet J; Wright LF; Vimr ER
    J Bacteriol; 2006 Sep; 188(17):6195-206. PubMed ID: 16923886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.
    Frasa H; Procee J; Torensma R; Verbruggen A; Algra A; Rozenberg-Arska M; Kraaijeveld K; Verhoef J
    J Clin Microbiol; 1993 Dec; 31(12):3174-8. PubMed ID: 7508454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialic Acid-Siglec-E Interactions During
    Mukherjee K; Khatua B; Mandal C
    Front Immunol; 2020; 11():332. PubMed ID: 32184783
    [No Abstract]   [Full Text] [Related]  

  • 25. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional relationships of the sialyltransferases involved in expression of the polysialic acid capsules of Escherichia coli K1 and K92 and Neisseria meningitidis groups B or C.
    Steenbergen SM; Vimr ER
    J Biol Chem; 2003 Apr; 278(17):15349-59. PubMed ID: 12578835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical validation of an
    Chorro L; Ndreu D; Patel A; Kodali S; Li Z; Keeney D; Dutta K; Sasmal A; Illenberger A; Torres CL; Pan R; Silmon de Monerri NC; Chu L; Simon R; Anderson AS; Donald RGK
    Microbiol Spectr; 2024 Jun; 12(6):e0421323. PubMed ID: 38700324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective synthesis and labeling of the polysialic acid capsule in Escherichia coli K1 strains with mutations in nanA and neuB.
    Vimr ER
    J Bacteriol; 1992 Oct; 174(19):6191-7. PubMed ID: 1400168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the recognition of hypermucoviscous
    Campanero-Rhodes MA; Martí S; Hernández-Ortiz N; Cubero M; Ereño-Orbea J; Ardá A; Jiménez-Barbero J; Ardanuy C; Solís D
    Front Immunol; 2024; 15():1436039. PubMed ID: 39148735
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.
    Saha S; Coady A; Sasmal A; Kawanishi K; Choudhury B; Yu H; Sorensen RU; Inostroza J; Schoenhofen IC; Chen X; Münster-Kühnel A; Sato C; Kitajima K; Ram S; Nizet V; Varki A
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
    Stein DM; Robbins J; Miller MA; Lin FY; Schneerson R
    Vaccine; 2006 Jan; 24(3):221-8. PubMed ID: 16125824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli.
    Torensma R; van Wijk A; Visser MJ; Bouter A; Rozenberg-Arska M; Verhoef J
    J Clin Microbiol; 1991 Jul; 29(7):1356-8. PubMed ID: 1885731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.
    Higuchi H; Shoji T; Iijima S; Nishijima K
    Biosci Biotechnol Biochem; 2016 Jun; 80(6):1141-8. PubMed ID: 26923638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier.
    Hoffman JA; Wass C; Stins MF; Kim KS
    Infect Immun; 1999 Jul; 67(7):3566-70. PubMed ID: 10377140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
    Phongsisay V
    Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.
    Chen GY; Brown NK; Zheng P; Liu Y
    Glycobiology; 2014 Sep; 24(9):800-6. PubMed ID: 24996822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escherichia coli O-antigen capsule (group 4) is essential for serum resistance.
    Biran D; Rosenshine I; Ron EZ
    Res Microbiol; 2020 Mar; 171(2):99-101. PubMed ID: 31982499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.